Rising aging population, prone to chronic conditions, propels the demand for in vitro diagnostics. Technological advancements in in vitro diagnostic techniques boost the industry development. The complexity and cost of FDA approval and lack of transp... Explore Report »
Research Reports in Clinical Diagnostics
Showing 10 results in Clinical Diagnostics
Rising global female aging population is increasing demand for menopause therapies. Higher healthcare spending is improving access to hormone treatment services. High therapy cost limits adoption in price-sensitive markets. Growing demand for bioiden... Explore Report »
Advancements in molecular diagnostics enhance the precision and turnaround time of sepsis detection. Compared to older methods, techniques like PCR and NGS allow for faster identification of pathogens. Biomarker-based testing boosts early-stage detec... Explore Report »
Cancer biomarkers are measurable signals within DNA, RNA, or metabolic activity that assist in detecting cancer presence, prognosis level, and guiding and choosing therapy options and monitoring therapy reactions. The market includes tissue tests and... Explore Report »
Global atopic dermatitis clinical trials market size was valued at USD 2.87 billion in 2025. The market is anticipated to grow from USD 3.18 billion in 2026 to USD 7.46 billion by 2034, exhibiting a CAGR of 11.20% during the forecast period. 2025 Mar... Explore Report »
The Real-time PCR, Digital PCR, And End-point PCR Market size was valued at USD 8.23 billion in 2025 and is anticipated to exhibit the CAGR of 4.3% during the forecast period. The growth is driven by rise in cases of infectious diseases, advancement ... Explore Report »
The Europe point of care (PoC) diagnostics market size was valued at USD 9.28 billion in 2024, growing at a CAGR of 3.92% from 2025-2034. Key factors driving demand include rising shift towards self-testing, supportive government policies and healthc... Explore Report »
The global point of care (PoC) diagnostics market size was valued at USD 60.99 billion in 2025, growing at a CAGR of 9.40% from 2026-2034. Key factors driving demand include rising demand for rapid and accurate testing solutions, government and insti... Explore Report »
The U.S. point of care (PoC) diagnostics market size was valued at USD 9.69 billion in 2024, growing at a CAGR of 6.88% from 2025-2034. Key factors driving demand include shift towards value based care and decentralized testing, supportive government... Explore Report »
The U.S. C-reactive protein testing market size was valued at USD 769.66 million in 2024, growing at a CAGR of 5.02% from 2025 to 2034. Key factors driving demand for C-reactive protein testing include growing demand for precision medicine, rising he... Explore Report »
Download Sample Report
Please fill out the form to receive sample pages of the report.